Sanofi's Brandicourt Pushes for Speedy Zika Vaccine DevelopmentBy
Drugmaker building on success of Dengvaxia dengue vaccine
Zika initial investment `won't be too big' thanks to Dengvaxia
Sanofi Chief Executive Officer Olivier Brandicourt is pushing for speedy development of a Zika virus vaccine, building on the company’s success in bringing the first inoculation against dengue to market.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.